VANCOUVER, BC — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, announced it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the… Read More
PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial Confirmatory trial found PADCEV plus pembrolizumab nearly doubled median overall survival compared to standard of care platinum-based chemotherapy NEW YORK &… Read More
VANCOUVER, BC – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted… Read More
Salmon researchers from British Columbia are embarking on a three-year study to understand and help mitigate the cumulative threats affecting the vulnerable species in the province’s watersheds. The Watershed Futures… Read More
Beazley, the leading specialty insurer, has named Patricia Kocsondy as Head of Global Cyber Digital Risks. Ms Kocsondy will be responsible for setting the global product and distribution strategy for… Read More
